Rb is known to be inactivated through hyper-phosphorylation, and distinct phosphorylation patterns are observed in different cancer types, suggesting that phosphorylation-based mechanisms may drive Rb dysfunction in a cancer-specific manner [53]. This evidence concerns the gene RB1 and cancer.